Frequently Asked Questions
About the Undiagnosed Diseases Network
What is the Undiagnosed Diseases Network (UDN)?
The UDN is a research study funded by the National Institutes of Health Common Fund. The UDN is made up of clinical and research centers across the United States working to improve diagnosis and care of patients with undiagnosed diseases.
What is the purpose of the UDN?
The UDN has two main goals:
1. To provide answers for patients and families affected by mysterious conditions, and
2. To learn more about rare and common diseases.
Where are the UDN clinical sites?
– Bethesda, MD (National Institutes of Health)
– Boston, MA (Brigham and Women’s Hospital, Boston Children’s Hospital, and Massachusetts General Hospital)
– Durham, NC (Duke University and Columbia University)
– Houston, TX (Baylor College of Medicine)
– Los Angeles, CA (University of California, Los Angeles)
– Miami, FL (University of Miami School of Medicine)
– Nashville, TN (Vanderbilt University Medical Center)
– Philadelphia, PA (Children’s Hospital of Philadelphia and University of Pennsylvania)
– Salt Lake City, UT (University of Utah)
– Seattle, WA (University of Washington School of Medicine and Seattle Children’s Hospital)
– Stanford, CA (Stanford Medicine)
– St. Louis, MO (Washington University in St. Louis)
What is unique about the UDN?
The UDN is trying to solve the most challenging medical mysteries by:
– Bridging the gap between clinical care and research.
– Using genetic data to try to find diagnoses.
– Working with researchers to figure out how diseases affect the body, which may lead to treatments.
– Training other doctors, nurses, genetic counselors, and scientists to use this new approach.
What is an undiagnosed disease?
An undiagnosed disease is a medical condition without a known cause despite a lot of evaluation.
What is a rare disease?
A rare disease is a disease that affects fewer than 200,000 people in the United States. There are so many separate rare diseases, that overall 1 in 10 people have a rare disease.
Who is eligible for the UDN study?
– Have a condition that remains undiagnosed despite thorough evaluation by a healthcare provider
– Have at least one objective finding
– Agree to the storage and sharing of information and biomaterials in an identified fashion amongst the UDN centers, and in a de-identified fashion to research sites beyond the network
Applying to the UDN
How do I apply to the UDN study?
Before applying to the UDN, it is important to discuss the study with a healthcare provider. You will also need an email address and access to the Internet. If you do not have an email address and access to the Internet, you can request a paper application by calling 1-844-RING-UDN (1-844-746-4836). You will also need to ask your healthcare provider to write a study recommendation letter. The study recommendation letter must include:
– A summary of medical problems
– Date when symptoms were first noticed
– Previous diagnoses
– History of evaluations and tests
– History of treatments and medications
– Current medications
– Family history
– Healthcare provider’s diagnostic thoughts
– For pediatric patients: prenatal and birth history
Once you have the study recommendation letter, you can fill out an online application through our website, which we call the UDN Gateway.
You will submit the study recommendation letter directly to this website. It should take less than 20 minutes to complete the online application. Please DO NOT email the application or study recommendation letter to the UDN.
When the UDN has received your application, you will receive a confirmation email. The UDN will let you know if more information is needed before your application can be reviewed.
Why do I need a study recommendation letter from my healthcare provider?
The UDN evaluation is only one part of your medical care. Your healthcare provider has been with you before the UDN evaluation and will likely continue to provide your medical care after the UDN evaluation. If you are accepted into the UDN study, the UDN will provide information from the evaluation to you and to your healthcare provider. Your healthcare provider will be responsible for your follow-up medical care.
If my relative is a healthcare provider, can he/she write the study recommendation letter?
No. Study recommendation letters must be written by healthcare providers who are not related to the applicant.
I don’t have a primary healthcare provider and I don’t have health insurance. Can I still apply?
Yes, but you will need a study recommendation letter from a licensed healthcare provider. If you receive care in a clinic or other healthcare setting, you can discuss your application with a member of the medical team.
Having insurance is not a requirement to participate in this study. We aim to minimize your out of pocket costs as much as possible. If you are accepted into the UDN, talk with your clinical site representative about any possible charges you may incur.
More than one member of my family is affected by an undiagnosed condition. Do I need to submit an application for each person?
No, one application should be submitted even if there are multiple people affected in a family. This application should be for one individual, not the whole family (ex. “John Smith”, not “Smith Family”). You may attach multiple study recommendation letters to a single application.
If I need help submitting my application, who should I contact?
UDN Helpdesk staff are available to assist patients with submitting applications. The Helpdesk phone number is 1-844-746-4836.
If an applicant (or legal guardian) does not speak English, a translator will be used to facilitate the online application process. If an applicant does not have access to the Internet, a paper application can be requested through the Helpdesk. Paper applications are available in English and Spanish. Completed paper applications will be mailed to the Helpdesk for data entry and clinical site assignment. Applications completed in Spanish will be back-translated into English at the Helpdesk.
What happens with my application?
Most likely, your application will be assigned to the UDN clinical site that is closest to where you live. Sometimes it will be assigned to a clinical site based on other factors. The assigned UDN clinical site will then contact you, typically within one month of application submission, to request additional information, such as:
– Medical records
– Laboratory studies
– MRI, X-ray, or CT images (can be sent on CD)
– Photographs or videos
– Pathology slides and reports
– For pediatric patients: growth curves
In order to help with the application review process, you can begin to collect these records while preparing your application. However, please do not send medical records until you receive specific instructions to do so from a UDN clinical site.
Please use only the specific contact information that you receive from the clinical site for UDN related emails or to submit medical records. Please do not send these materials to the UDN Coordinating Center.
Once the UDN team has received all of the information necessary to review your application, they will review your application and make a decision about acceptance into the study. This review is expected to take about 6-8 weeks.
Can I choose which UDN clinical site I’m assigned to?
You may ask to be assigned to a specific UDN clinical site on your application if you want to. However, there is no guarantee that you will be assigned to that site.
If I apply, does that automatically mean that my application will be reviewed?
If I apply, does that automatically mean I can go to a UDN clinical site?
No. The UDN can only accept a small number of participants. The UDN team reviews each application very carefully to decide who can be accepted into the study. Even if you are not accepted, you might receive some useful feedback about your medical condition.
How will I find out the UDN’s decision?
We will contact you and your referring provider.
If my application is not accepted, can I ask someone to review the application again?
If you have new medical information, you can ask the UDN clinical site to review your application again. However, there is no guarantee that the decision will change. The UDN makes all decisions as a network. There is no process to request for someone else to review an application after it is not accepted.
UDN Evaluation Process
If I am accepted into the UDN study, what happens next?
You will work with a UDN clinical site to determine the dates for a 2-5 day visit to the clinical site. You will travel to your assigned UDN clinical site for a medical and research evaluation. You may also be asked to provide copies of additional medical records.
What will happen at the clinical site?
You will be asked to enroll in the study and sign a consent form. You will also be asked to provide information about the health of your family members and to give permission for photographs, blood samples, and other samples (such as skin) to be taken.
You may be asked to send a blood sample for genetic testing to the clinical site several weeks before your clinical evaluation. Based on the types of symptoms you have, various medical specialists will evaluate you during your clinical site visit. You will also be asked to fill out some forms and surveys regarding your health and your experience with the UDN before, during, and after the clinical site visit.
The UDN works to provide a similar experience for all UDN participants, however, practices may vary by clinical site.
Will participants also have DNA tested as part of this study?
Most, but not all of the time, blood will be taken for DNA testing. The hope is that DNA testing will help the UDN team diagnose conditions. You will be informed about how your DNA will be used. If available and willing to participate, your biological family members may also provide DNA samples for testing. Your UDN clinical site will determine which family members should be asked to participate. More information about genetic testing through the UDN is available in the Genetic Testing Handout.
There may be people who have a history that suggests that the undiagnosed disease is not genetic. If you suspect an environmental cause of your condition, be sure to say so on the application.
Why might my family members need to be tested?
If your DNA is being analyzed, it is helpful to also get blood from your family members to compare their genetic results with your genetic results. This helps the UDN team to assess the meaning of your results.
What if my family members are unable or unwilling to participate?
You may still qualify to participate. However, this situation may make it harder for the UDN team to find a diagnosis.
Do my family members or I have to pay for the genetic testing?
No. The UDN will cover the cost of genetic testing if you are accepted into the study.
What laboratory will do the genetic testing?
Baylor College of Medicine in Houston, Texas.
Will the UDN evaluation give me a diagnosis?
The goal is to give you a diagnosis, but this may not happen.
Will I receive treatment through the UDN?
No, treatment will usually not be provided as part of the UDN. Treatment will remain your and your referring healthcare provider’s responsibility. But you and your provider may receive treatment recommendations from the UDN.
What is the cost for participating if accepted?
We aim to minimize your out of pocket costs as much as possible. If you are accepted into the UDN, talk with your clinical site representative about any possible charges you may incur.
What happens after the UDN evaluation?
After the UDN evaluation, you and your referring provider will receive the information from the evaluation. Long term care will not be provided by the UDN. Some UDN participants may be eligible for other research studies at the UDN site or other academic centers.
You can call or email the Helpdesk at the UDN Coordinating Center to find out more about:
– Participating in the UDN research project
– What to include in the study recommendation letter
– The status of your application
– Requesting a paper application
Hours: Monday–Friday, 9am – 5pm ET
Phone: 1-844-746-4836 (1 844 Ring UDN)
Note: please do not contact the main hospital of the UDN clinical sites.